HCA Healthcare, Inc. $HCA Holdings Lifted by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 66.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 13,667 shares of the company’s stock after acquiring an additional 5,477 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in HCA Healthcare were worth $6,468,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in HCA. Palisade Asset Management LLC purchased a new stake in HCA Healthcare in the 3rd quarter worth approximately $26,000. Holos Integrated Wealth LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter worth $29,000. Ares Financial Consulting LLC acquired a new stake in HCA Healthcare during the fourth quarter valued at $31,000. JPL Wealth Management LLC acquired a new position in HCA Healthcare in the 3rd quarter worth about $33,000. Finally, Aventura Private Wealth LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter valued at about $34,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

HCA stock opened at $409.99 on Friday. The company has a 50-day moving average of $400.65 and a two-hundred day moving average of $462.43. The stock has a market capitalization of $90.95 billion, a price-to-earnings ratio of 14.10, a price-to-earnings-growth ratio of 1.30 and a beta of 1.12. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.HCA Healthcare’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same period in the prior year, the firm posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

Analysts Set New Price Targets

HCA has been the topic of several recent research reports. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday. Robert W. Baird cut their price target on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Wells Fargo & Company lowered their target price on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a research report on Monday, April 27th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $525.00 price target on shares of HCA Healthcare in a research report on Friday, April 24th. Finally, Truist Financial set a $413.00 price objective on HCA Healthcare in a report on Thursday, June 4th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $503.00.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.